Cross Atlantic Partners appeared to be the VC, which was created in 1994. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the New York.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Cross Atlantic Partners, startups are often financed by Abingworth, Sprout Group, Sofinnova Partners. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, Skyline Ventures, Partisan Management Group. In the next rounds fund is usually obtained by Three Arch Partners, Sofinnova Partners, Skyline Ventures.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Biotechnology, Internet. Among the various public portfolio startups of the fund, we may underline Labcyte, Sapphire Digital, QuesCom Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
Besides them, we counted 1 critical employee of this fund in our database.
Deals in the range of 10 - 50 millions dollars are the general things for fund. This Cross Atlantic Partners works on 17 percentage points more the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2008. Considering the real fund results, this VC is 5 percentage points less often commits exit comparing to other organizations. The average startup value when the investment from Cross Atlantic Partners is 10-50 millions dollars. The increased amount of exits for fund were in 2019. The fund is generally included in less than 2 deals every year.
Related Funds
Funds with similar focus
Fund Name | Location |
Arizona Bay LLC | California, San Francisco, United States |
Art and Culture | - |
aucfan Co.,Ltd. | Chiyoda, Japan |
Charlie | California, Los Angeles, United States |
China Union Holdings | China, Guangdong, Shenzhen |
Chuangling Capital | Beijing, Beijing, China |
Dezhong Capital | China, Chongqing, Chongqing Shi |
Enbrite.ly | England, London, United Kingdom |
Gorilla Capital | Eugene, Oregon, United States |
Nanjing Daofeng Investment | - |
North Castle Partners | Connecticut, Greenwich, United States |
Qianhai Dingfeng Investment | China, Guangdong, Shenzhen |
Quogue Capital | New York, New York, United States |
California, San Francisco, United States | |
TV Guide | Oklahoma, Tulsa, United States |
William Blair New World Ventures | Chicago, Illinois, United States |
WillowWorks | Columbus, Ohio, United States |
Yihang Funds | - |
Zhelitou | China, Hangzhou, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Sapphire Digital | $4M | 14 Oct 2008 | New Jersey, United States | ||
Labcyte | $3M | 26 Mar 2008 | San Jose, California, United States | ||
GQ Life Sciences | $4M | 24 Sep 2007 | Boston, Massachusetts, United States | ||
Acorda Therapeutics | $55M | 20 May 2003 | New York, United States | ||
Confluent Surgical | $20M | 25 Jun 2002 | Waltham, Massachusetts, United States | ||
Medivance | $16M | 18 Jun 2001 | Colorado, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Sapphire Digital | $4M | 14 Oct 2008 | New Jersey, United States | ||
Labcyte | $3M | 26 Mar 2008 | San Jose, California, United States | ||
GQ Life Sciences | $4M | 24 Sep 2007 | Boston, Massachusetts, United States | ||
Acorda Therapeutics | $55M | 20 May 2003 | New York, United States | ||
Confluent Surgical | $20M | 25 Jun 2002 | Waltham, Massachusetts, United States | ||
Medivance | $16M | 18 Jun 2001 | Colorado, United States |